18 results match your criteria: "National Institutes of Health Sciences[Affiliation]"

Possible determinants of physical fitness in Japanese school children: A cross-sectional study.

Paediatr Perinat Epidemiol

September 2024

Department of Environmental and Occupational Health, School of Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.

Background: Physical fitness is one of the most important health indicators in children. Although appropriate body composition or certain lifestyle factors such as frequent physical activity are thought to improve physical fitness, results of previous studies are inconsistent, and most studies were from Western countries.

Objectives: We investigated associations of body composition and modifiable lifestyle factors such as physical activity, screen time, diet and sleep duration with physical fitness in Japanese primary school children.

View Article and Find Full Text PDF

CRISPR/Cas9-Mediated Induction of Relapse-Specific and Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model.

Mol Pharmacol

April 2023

Department of Pediatrics, University of Yamanashi, Yamanashi, Japan (T.T.T.N., M.T., K.K., C.K., S.S., D.H., S.K., A.W., K.A., K.G., T.I.); Division of Medicinal Safety Science, National Institutes of Health Sciences, Kanagawa, Japan (Y.T.); and Advanced Diagnostic Research Department, Clinical Research Center, National Hospital Organization, Nagoya Medical Center, Japan (M.S., M.H.)

Article Synopsis
  • 6-Mercaptopurine (6-MP) is essential for treating childhood acute lymphoblastic leukemia (ALL) but can lead to relapse due to specific mutations in关键的代谢基因.
  • Researchers used the CRISPR/Cas9 system to create human leukemia cell lines with targeted R39Q and S103N mutations to study how these mutations contribute to 6-MP resistance.
  • The resulting 6-MP-resistant cell lines provide valuable models for understanding drug resistance mechanisms and developing new therapies for relapsed ALL.
View Article and Find Full Text PDF

Here, we report a draft genome sequence of Campylobacter jejuni strain Shizu21005, isolated from a food handler with no symptoms in Japan on March 2021. Its genome size was 1,656,785 bp, with 2 rRNAs, 35 tRNAs, and a coverage of 330×.

View Article and Find Full Text PDF

Characterization of a TNFR2-Selective Agonistic TNF-α Mutant and Its Derivatives as an Optimal Regulatory T Cell Expander.

J Immunol

April 2021

Laboratory of Cellular and Molecular Physiology, The Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Chuo-ku, Kobe 650-8586, Japan;

Regulatory T cells (Tregs) are a subpopulation of lymphocytes that play a role in suppressing and regulating immune responses. Recently, it was suggested that controlling the functions and activities of Tregs might be applicable to the treatment of human diseases such as autoimmune diseases, organ transplant rejection, and graft-versus-host disease. TNF receptor type 2 (TNFR2) is a target molecule that modulates Treg functions.

View Article and Find Full Text PDF

Inhaled ciclesonide (CIC), a corticosteroid used to treat asthma that is also being investigated for the treatment of corona virus disease 2019, hydrolyzes to desisobutyryl-ciclesonide (des-CIC) followed by reversible esterification when exposed to fatty acids in lungs. While previous studies have described the distribution and metabolism of the compounds after inhalation, spatial localization in the lungs remains unclear. We visualized two-dimensional spatial localization of CIC and its metabolites in rat lungs after administration of a single dose of a CIC aerosol (with the mass median aerodynamic diameter of 0.

View Article and Find Full Text PDF

The need to develop new tools and increase capacity to test pharmaceuticals and other chemicals for potential adverse impacts on human health and the environment is an active area of development. Much of this activity was sparked by two reports from the US National Research Council (NRC) of the National Academies of Sciences, Toxicity Testing in the Twenty-first Century: A Vision and a Strategy (2007) and Science and Decisions: Advancing Risk Assessment (2009), both of which advocated for "science-informed decision-making" in the field of human health risk assessment. The response to these challenges for a "paradigm shift" toward using new approach methodologies (NAMS) for safety assessment has resulted in an explosion of initiatives by numerous organizations, but, for the most part, these have been carried out independently and are not coordinated in any meaningful way.

View Article and Find Full Text PDF

CYP3A4 Induction in the Liver and Intestine of Pregnane X Receptor/CYP3A-Humanized Mice: Approaches by Mass Spectrometry Imaging and Portal Blood Analysis.

Mol Pharmacol

November 2019

Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba (K.K., G.M.); Discovery Drug Metabolism & Pharmacokinetics, Tsukuba Research Center, Taiho Pharmaceutical Co., Ltd., Ibaraki (J.Ku.); Chromosome Engineering Research Center (CERC), Tottori University, Tottori (S.A., S.T., M.O., Y.K.); Laboratory of Biofunctional Science, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Tokyo (K.I.); Division of Cellular and Molecular Toxicology, Biological Safety Research Center, National Institutes of Health Sciences, Kanagawa (S.K., J.Ka.); Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Kanagawa (J.Ka.); Analytical & Measuring Instruments Division, Shimadzu Corporation, Kyoto (T.Y.); and Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University, Tottori (Y.K.), Japan

Induction of cytochrome P450 enzyme 3A (CYP3A) in response to pregnane X receptor (PXR) activators shows species-specific differences. To study the induction of human CYP3A in response to human PXR activators, we generated a double-humanized mouse model of PXR and CYP3A. CYP3A-humanized mice generated by using a mouse artificial chromosome (MAC) vector containing the entire genomic human CYP3A locus (hCYP3A-MAC mouse line) were bred with PXR-humanized mice in which the ligand-binding domain of mouse PXR was replaced with that of human PXR, resulting in double-humanized mice (hCYP3A-MAC/hPXR mouse line).

View Article and Find Full Text PDF

Occludin (OCLN), an integral tetra-spanning plasma membrane protein, is a host entry factor essential for hepatitis C virus (HCV) infection, making it a promising host-targeting molecule for HCV therapeutic intervention. We previously generated rat anti-OCLN monoclonal antibodies (mAbs) that strongly prevented HCV infection in vitro and in vivo. In the present study, we attempted to improve the druggability of the extracellular loop domain-recognizing anti-OCLN mAbs, namely clones 1-3 and 37-5, using genetic engineering.

View Article and Find Full Text PDF
Article Synopsis
  • Study Overview
  • : The research analyzed atypical enteropathogenic E. coli (aEPEC) strains from poultry fecal samples in Japan and Bangladesh using molecular methods, revealing a higher prevalence of phylogroup A compared to B1.
  • Virulence and Resistance Findings
  • : Intimin type β1 was found to be common in both phylogroups, particularly within group B1 strains, with a significant portion showing high rates of antimicrobial resistance, especially among strains from Bangladesh.
  • Implications of Results
  • : The study indicates that Japanese poultry may serve as a reservoir for aEPEC strains, which are distinct from human strains, while Bangladeshi strains exhibit lower virulence but higher resistance
View Article and Find Full Text PDF

The Japanese food allergen labeling regulation was designed to match real Japanese food allergy circumstances and also to be enforced effectively; thus, (1) regulated food allergens were selected by prevalence and seriousness according to food allergy surveys in Japan; (2) the detection criterion for ELISA monitoring, 10 μg food allergen protein/g (or mL) food, was set up as the threshold value to regulate commercial prepackaged foods; and (3) official food allergen analytical methods, which can determine the threshold value accurately, were developed. These three points are distinctive from other countries. Furthermore, as an on-going project, the regulation has been amended according to food allergy circumstances and requirements of society.

View Article and Find Full Text PDF

Creation of a Claudin-2 Binder and Its Tight Junction-Modulating Activity in a Human Intestinal Model.

J Pharmacol Exp Ther

December 2017

Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (Mu.T., M.I., S.N., A.W., Y.O., T.D., K.Y., J.K., M.K.); Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, National Institute of Biomedical Innovation, Osaka, Japan (Mu.T., H.S., J.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (Mi.T.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (M.F.); Graduate School of Medicine and Graduate School of Dentistry, Osaka University, Osaka, Japan (J.K.); Division of Mucosal Immunology, Department of Microbiology and Immunology and International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (J.K.); and Department of Microbiology and Immunology, Kobe University Graduate School of Medicine, Hyogo, Japan (J.K.)

Disruption of the gastrointestinal epithelial barrier is a hallmark of chronic inflammatory bowel diseases (IBDs). The transmembrane protein claudin 2 (CLDN2) is a component of epithelial tight junctions (TJs). In the intestines of patients with IBDs, the expression of the pore-forming TJ protein CLDN2 is upregulated.

View Article and Find Full Text PDF

Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules.

Mol Pharmacol

March 2017

Division of Molecular Target and Gene Therapy Products (K.O., N.O., T.H., N.S., M.N.), and Division of Organic Chemistry (T.S., Y.D., M.K.), National Institutes of Health Sciences, Tokyo; Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima (K.O., R.O., R.S., A.I., H.K., H.S.); Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo (Y.I., M.I., Y.H.); Showa Pharmaceutical University, Machida (S.I.), Japan

Development of novel small molecules that selectively degrade pathogenic proteins would provide an important advance in targeted therapy. Recently, we have devised a series of hybrid small molecules named SNIPER (specific and nongenetic IAP-dependent protein ERaser) that induces the degradation of target proteins via the ubiquitin-proteasome system. To understand the localization of proteins that can be targeted by this protein knockdown technology, we examined whether SNIPER molecules are able to induce degradation of cellular retinoic acid binding protein II (CRABP-II) proteins localized in subcellular compartments of cells.

View Article and Find Full Text PDF

This study was performed to determine the prevalence, antimicrobial susceptibility, and genetic relatedness of Salmonella enterica subsp. enterica and Campylobacter spp. in poultry meat, and to analyze the association of genetic types of these bacteria with their geographical distribution and antimicrobial resistance profiles.

View Article and Find Full Text PDF

No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasis.

Drug Metab Dispos

May 2015

Department of Gastroenterology (T.K., S.H., Y.A., K.A., K.T., K.S., R.O., S.I., T.M.), Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine (H.I.), and Institute of Medical Science (A.O.), Tokai University School of Medicine, Isehara, Japan; Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan (T.N.); Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan (K.T., R.H., S.M.); Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan (H.E., H.S.); Department of Gastroenterology, Juntendo University Urayasu Hospital, Urayasu, Japan (T.K.); International University of Health and Welfare, Research Centre of Clinical Medicine, Sanno Hospital, Tokyo, Japan (Y.H.); Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan (C.O.); Ikegami General Hospital, Tokyo, Japan (M.W.); Division of Medicinal Safety Science, National Institutes of Health Sciences, Tokyo, Japan (M.T., Y.S., K.M.); and Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan (H.T.).

European studies have revealed that the ABCB11 c.1331T>C (V444A) polymorphism (rs2287622) C-allele frequency is higher among patients with drug-induced cholestasis. Given the low incidence of this disease, however, this association has not been sufficiently elucidated.

View Article and Find Full Text PDF

Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus.

J Pharmacol Exp Ther

April 2015

Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (M.Y., M.I., S.N., A.W., K.Y., M.K.); Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (Y.S., M.F.); and Graduate School of Biological Science, Tokyo University of Science, Chiba, Japan (Y.S.)

Claudin-1 (CLDN1), a known host factor for hepatitis C virus (HCV) entry and cell-to-cell transmission, is a target molecule for inhibiting HCV infection. We previously developed four clones of mouse anti-CLDN1 monoclonal antibody (mAb) that prevented HCV infection in vitro. Two of these mAbs showed the highest antiviral activity.

View Article and Find Full Text PDF

Development of an anti-claudin-3 and -4 bispecific monoclonal antibody for cancer diagnosis and therapy.

J Pharmacol Exp Ther

October 2014

Laboratories of Bio-Functional Molecular Chemistry (X.L., M.I., A.W., Y.Ka., Y.Ki., K.Y., M.K.) and Analytical Chemistry (T.Y., T.U.), Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan; Division of Biological Chemistry and Biologicals, National Institutes of Health Sciences, Tokyo, Japan (M.T., A.I.-W.); Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan (M.F.); and Department of Molecular Pathology, Nara Medical University, Nara, Japan (H.K.)

Most malignant tumors are derived from epithelium, and claudin (CLDN)-3 and CLDN-4 are frequently overexpressed in such tumors. Although antibodies have potential in cancer diagnostics and therapy, development of antibodies against CLDNs has been difficult because the extracellular domains of CLDNs are too small and there is high homology among human, rat, and mouse sequences. Here, we created a monoclonal antibody that recognizes human CLDN-3 and CLDN-4 by immunizing rats with a plasmid vector encoding human CLDN-4.

View Article and Find Full Text PDF

Protective effect of dextromethorphan against endotoxic shock in mice.

Biochem Pharmacol

January 2005

Neuropharmacology Section, Laboratory of Pharmacology and Chemistry, NCI, National Institute of Environmental Health Sciences, National Institutes of Health Sciences, Research Triangle Park, NC 27709, USA.

Dextromethorphan (DM) is a dextrorotatory morphinan and an over-the-counter non-opioid cough suppressant. We have previously shown that DM protects against LPS-induced dopaminergic neurodegeneration through inhibition of microglia activation. Here, we investigated protective effects of DM against endotoxin shock induced by lipopolysaccharide/d-galactosamine (LPS/GalN) in mice and the mechanism underlying its protective effect.

View Article and Find Full Text PDF